Andrea Viecelli MD, Phd

Dr. Andrea Viecelli is a Senior Lecturer at the Faculty of Medicine, University of Queensland, and a nephrologist at Princess Alexandra Hospital in Brisbane, Australia. She completed her Ph.D. on strategies to improve vascular access outcomes in patients on hemodialysis through the University of Queensland in 2019. She is a clinical trialist of the Australasian Kidney Trials Network and a lead investigator of the FAVOURED study, an international, multicentre randomized controlled trial of fish oil and aspirin for preventing arteriovenous fistula failure.

As a coordinating committee member of the global Standardised outcomes in Nephrology (SONG) initiative, she is leading an international collaborative study (VALID) to validate standardized core outcome measures for vascular access function. Her research focus is on clinical trials, meta-analyses, and qualitative research in patient-important outcomes. She is an academic editor for PLOS ONE and a reviewer for several international high-impact journals. She has published over 30 peer-reviewed articles, 5 book chapters and received numerous awards, including a Kidney Health Australia Clinical Science Award and a Young Investigator Award at the Australian and New Zealand Society of Nephrology Annual Scientific Meeting in 2016 and 2017, and two Young Investigator Award at the ERA-EDTA congress in 2017 and 2018, respectively.